NCT00680680已完成不适用
Phase 4 Study of Dual Five Alpha Reductase Inhibition Combined With Alpha Blockade in Men With Refractory Urinary Retention Secondary to BPH
Franklin D. Gaylis, MD Inc.0 个研究点目标入组 20 人开始时间: 2004年5月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
To determine whether the addition of a dual Five Alpha Reductase Inhitor (Dutasteride) will alleviate urinary retention secondary to BPH in who have failed a voiding trial without a catheter. Following treatment with an Alpha Blocker alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 90 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Males betewen the ages of 50 and 90 years of age.Written informed consent.
- •Men with acute urinary retention attributed to bladder outlet obstruction caused by BPH, who have failed atleast 1 week trial of alpha blocker treatment.
- •PSA level equal to or greater than 1.5ng/ml and equal to or less than 15 ng/ml.
排除标准
- •Urinary retention attributed to a neurogenic or myogenic bladder dysfunction.
- •Use of psychotrophic medications.
- •Use of antichollinergic medications.
- •Prostate cancer.
- •Allery to five alpha reductase inhibitors.
- •Prior prostate surgery.
- •Urethral stricture.
- •Bladder calculi.
- •Invasive bladder cancer.
- •Inability to understand or agree with the requirements of the study.
- •Any investigational drug received within 30 days prior of study entry.
研究者
相似试验
已完成
3 期
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and FunctionHeart Defects, CongenitalTransposition of Great Vessels With Ventricular InversionNCT03049540Insel Gruppe AG, University Hospital Bern100
已完成
4 期
Dutasteride Treatment for the Reduction of Heavy Drinking in MenAlcohol AbuseAlcohol DependenceAlcoholismNCT01758523UConn Health189
已完成
3 期
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN NeoplasiaProstate CancerNCT00780754Kaunas University of Medicine200
已完成
2 期
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate CancerProstate CancerNCT01393730Mary-Ellen Taplin, MD40
已完成
4 期
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenNeoplasms, ProstateNCT00363311GlaxoSmithKline302